Showing 2 posts of 2 posts found.

Takeda signs deal with Sosei Heptares worth $1.2 billion

August 6, 2019
Manufacturing and Production GPCR, Sosei Heptares, Takeda, pharma, sosei

Takeda has entered into a partnership with Sosei Heptares to develop drugs that modulate G protein-coupled receptor (GPCR) targets. The …

Shire image

Shire signs CNS disorders deal with Heptares

March 23, 2012
Research and Development A2A, CNS, GPCR, Heptares, Shire

Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …

Latest content